{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** IV Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To treat presumed acute inflammatory demyelination To hasten functional recovery of vision and motor function\n\n*   **Treatment:** Gastroprotection (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To prevent gastritis/peptic ulceration associated with high-dose steroids\n\n*   **Treatment:** DVT Prophylaxis (e.g., LMWH)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Patient has significant immobility and dense hemiparesis\n\n*   **Treatment:** Long-term Disease Modifying Therapy (e.g., Ocrelizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Must confirm specific diagnosis (MS vs NMO vs MOGAD) via antibody status and CSF results before selecting the appropriate agent\n\n\ntreatments = [{\"treatment\": \"IV Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To treat presumed acute inflammatory demyelination\", \"To hasten functional recovery of vision and motor function\"]}, {\"treatment\": \"Gastroprotection (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"To prevent gastritis/peptic ulceration associated with high-dose steroids\"]}, {\"treatment\": \"DVT Prophylaxis (e.g., LMWH)\", \"timing\": \"Start Now\", \"reasons\": [\"Patient has significant immobility and dense hemiparesis\"]}, {\"treatment\": \"Long-term Disease Modifying Therapy (e.g., Ocrelizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Must confirm specific diagnosis (MS vs NMO vs MOGAD) via antibody status and CSF results before selecting the appropriate agent\"]}]"
}